Found: 15
Select item for more details and to access through your institution.
Dual Inhibition of B7-H3 and EGFR Overcomes Acquired Chemoresistance in Colon Adenocarcinoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1750, doi. 10.7150/jca.91089
- By:
- Publication type:
- Article
TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41419-023-06408-5
- By:
- Publication type:
- Article
Prognostic and clinical significance of subcellular CDC27 for patients with rectal adenocarcinoma treated with adjuvant chemotherapy.
- Published in:
- Oncology Letters, 2022, v. 24, n. 1, p. N.PAG, doi. 10.3892/ol.2022.13358
- By:
- Publication type:
- Article
Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 4, p. 1043, doi. 10.1007/s00432-019-02874-7
- By:
- Publication type:
- Article
The Clinical Relevance of Frequent Germline Genetic Variants Detected by Targeted Sequencing in Patients With Rectal Adenocarcinoma (READ).
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2020, v. 17, n. 3, p. 291, doi. 10.21873/cgp.20189
- By:
- Publication type:
- Article
Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27620-x
- By:
- Publication type:
- Article
Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03692-8
- By:
- Publication type:
- Article
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2283, doi. 10.1007/s00262-023-03416-4
- By:
- Publication type:
- Article
Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 10, p. 2937, doi. 10.1007/s00262-021-02894-8
- By:
- Publication type:
- Article
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00881-5
- By:
- Publication type:
- Article
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.
- Published in:
- Theranostics, 2021, v. 11, n. 8, p. 3661, doi. 10.7150/thno.53176
- By:
- Publication type:
- Article
Immunogenic Cell Death by the Novel Topoisomerase I Inhibitor TLC388 Enhances the Therapeutic Efficacy of Radiotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1218, doi. 10.3390/cancers13061218
- By:
- Publication type:
- Article
Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 462, doi. 10.3390/cancers12020462
- By:
- Publication type:
- Article
ATAD3A stabilizes GRP78 to suppress ER stress for acquired chemoresistance in colorectal cancer.
- Published in:
- Journal of Cellular Physiology, 2021, v. 236, n. 9, p. 6481, doi. 10.1002/jcp.30323
- By:
- Publication type:
- Article
Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46254-1
- By:
- Publication type:
- Article